Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Business Today.
Press releases published on May 1, 2025
VTRS COURT DEADLINE: Viatris Inc. (NASDAQ:VTRS) Investors with Losses have Until June 3 before the Expiration of the Class Action Deadline – Contact BFA Law
GlobeNewswire
·
May 1, 2025
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
RC COURT DEADLINE: Ready Capital (NYSE:RC) Investors with Losses have Until May 5 before the Expiration of the Class Action Deadline – Contact BFA Law
GlobeNewswire
·
May 1, 2025
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
FLNC COURT DEADLINE: Fluence Energy, Inc. (NASDAQ:FLNC) Investors with Losses have Until May 12 before the Expiration of the Class Action Deadline – Contact BFA Law
GlobeNewswire
·
May 1, 2025
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
Freddie Mac Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 1, 2025
MCLEAN, Va., May 01, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today reported its First Quarter 2025 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company’s Form 10-Q and …
Cumulus Media Reports Operating Results for the First Quarter 2025
GlobeNewswire
·
May 1, 2025
ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (NASDAQ: CMLS) (the "Company," "Cumulus Media," "we," "us," or "our") today announced operating results for the three months ended March 31, 2025. Mary G. Berner, President and Chief Executive …
HBX Group Wins “AI-Based TravelTech Solution of the Year” in 2025 TravelTech Breakthrough Awards Program
GlobeNewswire
·
May 1, 2025
LOS ANGELES, May 01, 2025 (GLOBE NEWSWIRE) -- TravelTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout travel technology companies, products and services around the globe, today announced that …
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
GlobeNewswire
·
May 1, 2025
SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it has appointed Dr. …
ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025
GlobeNewswire
·
May 1, 2025
LEIDEN, Netherlands …
ABC Construction Safety Report: Jobsites Can Be Nearly 7 Times Safer With Health and Safety Best Practices
GlobeNewswire
·
May 1, 2025
WASHINGTON, May 01, 2025 (GLOBE NEWSWIRE) -- Associated Builders and Contractors today released its 2025 Health and Safety Performance Report, an annual guide to construction jobsite health and safety best practices. As a proud sponsor, ABC published the …
BrainsWay to Showcase Deep TMS at the 2025 American Psychiatric Association Annual Meeting in Los Angeles
GlobeNewswire
·
May 1, 2025
BURLINGTON, Mass. and JERUSALEM, May 01, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …
Governance is the Top Priority for Companies Using Agentic AI Systems
GlobeNewswire
·
May 1, 2025
DENVER, May 01, 2025 (GLOBE NEWSWIRE) -- Gravitee, the leading Agentic API and Event Management company, announces the results of a survey on the use of Agentic AI systems and Large Language Models (LLMs) by large and midsize companies. A key takeaway from …
Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference
GlobeNewswire
·
May 1, 2025
SAN FRANCISCO and BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will present at the Bank of America Health Care Conference on Tuesday, May 13, 2025, at 1:40 p.m. P.T. / 4:40 p …
Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
May 1, 2025
MORRISVILLE, N.C., May 01, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its first quarter 2025 …
Rezolute to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 1, 2025
REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism, …
Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
GlobeNewswire
·
May 1, 2025
SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2025 financial results after market close …
Top KingWin Ltd Announces 1-For-25 Reverse Share Split
GlobeNewswire
·
May 1, 2025
Guangzhou, China, May 01, 2025 (GLOBE NEWSWIRE) -- Top KingWin Ltd (“Top KingWin” or the “Company”) (Nasdaq: WAI) today announced that it will effect a reverse share split of its outstanding class A ordinary shares, par value $0.0001 per share (the “ …
Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development
GlobeNewswire
·
May 1, 2025
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that Nicole Davarpanah, M.D., J.D. has …
Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights
GlobeNewswire
·
May 1, 2025
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, prior to the open of financial markets …
ImmunoGenesis Expands Phase 1a/b Trial of IMGS-001 for Advanced Solid Tumors to Ochsner MD Anderson Cancer Center
GlobeNewswire
·
May 1, 2025
First dual-specific PD-L1/PD-L2 antibody with cytotoxic killing function is designed to treat the many “immune-excluded” cancers that are resistant to existing immunotherapies Promising early signals of activity seen as Phase 1 dose escalation proceeds …
AgEagle Aerial Systems Showcases eBee VISION and eBee TAC Capability to European Customers
GlobeNewswire
·
May 1, 2025
Unmanned Aerial Systems (UAS) manufacturer fields demonstrations for decision makers in Baltic states to answer region’s defense and public safety needs WICHITA, Kan., May 01, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading …